AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INTEGRAL DIAGNOSTICS LTD

2.320

0.000

Volume:1.81M

Turnover:4.19M

Market Cap:863.54M

PE:114.94

High:2.350

Open:2.300

Low:2.300

Close:2.320

Loading ...

Overview Company News Filings

Government Seeks to Soothe Market Turmoil as IHSG Plummets

OJK to Unveil New Policy Amid Market Turmoil as IHSG Plummets

Economist Links IHSG Plummet to TNI Bill Revision

IDX Reports Rp246.1tn Securities Transactions, Launches Repo Trading on SPPA

Insider Actions Highlight 3 Undervalued Small Caps In Global Market

Simply Wall St.

BUZZ-Australia's Integral Diagnostics rises on Citi's upgrade to 'Buy' rating

Integral Diagnostics Ltd : Citi Upgrades Rating to Buy From Neutral

THOMSON REUTERS

Investors Shouldn't Be Too Comfortable With Integral Diagnostics' (ASX:IDX) Earnings

Simply Wall St.

ASX Value Stocks: Uncovering 3 Companies Possibly Trading Below Fair Value Estimates

Simply Wall St.

Don't Buy Integral Diagnostics Limited (ASX:IDX) For Its Next Dividend Without Doing These Checks

Simply Wall St.

Slammed 29% Integral Diagnostics Limited (ASX:IDX) Screens Well Here But There Might Be A Catch

Simply Wall St.

Small companies, big swings and four future leaders that stand out

Are Poor Financial Prospects Dragging Down Integral Diagnostics Limited (ASX:IDX Stock?

Simply Wall St.

Integral Diagnostics First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

Canaccord Genuity Upgrades Integral Diagnostics to Buy from Hold; Price Target is AU$2.90

MT Newswires Live

Integral Diagnostics Limited's (ASX:IDX) market cap dropped AU$178m last week; individual investors who hold 51% were hit as were institutions

Simply Wall St.

Integral Diagnostics Ltd (ASX:IDX) (H1 2025) Earnings Call Highlights: Strong Revenue Growth ...

BUZZ-Australia's Integral Diagnostics slumps on HY results, estimate miss

This ASX healthcare stock is crashing 30% on half year results

Integral Diagnostics Fiscal H1 Loss Narrows as Revenue Rises

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IDX.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDX.AU\",,,,,undefined,":{"symbol":"IDX.AU","market":"AU","secType":"STK","nameCN":"INTEGRAL DIAGNOSTICS LTD","latestPrice":2.32,"timestamp":1749522316179,"preClose":2.32,"halted":0,"volume":1805757,"delay":0,"nameEN":"INTEGRAL DIAGNOSTICS LTD","floatShares":348398974,"shares":372215519,"eps":0.020184,"marketStatus":"Trading","change":0,"latestTime":"06-10 12:25:55 AEST","open":2.3,"high":2.35,"low":2.3,"amount":4189177,"amplitude":0.021552,"askPrice":2.32,"askSize":9072,"bidPrice":2.31,"bidSize":56141,"shortable":3,"etf":0,"ttmEps":0.020184,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1749535200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":2.32,"dividendRate":0.025,"openAndCloseTimeList":[[1749513600000,1749535200000]],"volumeRatio":4.433063,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDX.AU\",,,,,undefined,":{"symbol":"IDX.AU","floatShares":348398974,"roa":"2.56%","roe":"1.14%","lyrEps":-0.259956,"volumeRatio":4.433063,"shares":372215519,"dividePrice":0.058,"high":2.35,"amplitude":0.021552,"preClose":2.32,"low":2.3,"week52Low":1.888,"pbRate":"1.25","psRate":"1.76","week52High":3.163,"institutionHeld":0,"latestPrice":2.32,"committee":0.721773,"eps":0.020184,"divideRate":0.025,"volume":1805757,"delay":0,"ttmEps":0.020184,"open":2.3,"prevYearClose":2.876,"prevWeekClose":2.32,"prevMonthClose":2.42,"prevQuarterClose":2.29,"fiveDayClose":2.44,"twentyDayClose":2.48,"sixtyDayClose":2.21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDX.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520670896","title":"Government Seeks to Soothe Market Turmoil as IHSG Plummets","url":"https://stock-news.laohu8.com/highlight/detail?id=2520670896","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520670896?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:05","pubTimestamp":1742295938,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - The Composite Stock Price Index, or IHSG plummeted by 5 percent on Tuesday, March 18, 2025. In response to the collapse of the domestic stock market, Finance Minister Sri Mulyani presented the latest report on state revenue, hoping to calm the market.Sri Mulyani stated that the gross revenue of the State Budget  grew by 6.6 percent in March 2025. She mentioned that there had been a turnaround, better than what the Ministry of Finance reported last week. \"This is meant to calm down the media and the market,\" she said in a press conference at the central office of the Directorate General of Taxation in Jakarta, on Tuesday, March 18, 2025.","market":"fut","thumbnail":"https://statik.tempo.co/data/2025/03/18/id_1385492/1385492_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/03/18/id_1385492/1385492_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1987978/government-seeks-to-soothe-market-turmoil-as-ihsg-plummets","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["IDX","IDX.AU","BK4213","GDP","BK7124"],"gpt_icon":0},{"id":"2520623373","title":"OJK to Unveil New Policy Amid Market Turmoil as IHSG Plummets","url":"https://stock-news.laohu8.com/highlight/detail?id=2520623373","media":"Tempo","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520623373?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:40","pubTimestamp":1742294455,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -The Financial Services Authority  is preparing to introduce a new policy in response to recent market turbulence. Inarno Djajadi, Chief Executive of Capital Market Supervision, Derivative Finance, and the Carbon Exchange at OJK, announced that the policy will be unveiled on Wednesday, March 19, 2025, at 10:00 AM.\"We have formulated several policies to address the current market conditions. If all goes well, we will announce one of them tomorrow,\" Inarno stated during a press conference at the Indonesia Stock Exchange  in South Jakarta on Tuesday, March 18, 2025.He also noted that the House of Representatives fully supports OJK’s efforts to maintain market stability.","market":"fut","thumbnail":"https://statik.tempo.co/data/2024/12/30/id_1365769/1365769_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2024/12/30/id_1365769/1365769_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1987965/ojk-to-unveil-new-policy-amid-market-turmoil-as-ihsg-plummets","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7124","IDX.AU","IDX"],"gpt_icon":0},{"id":"2520364386","title":"Economist Links IHSG Plummet to TNI Bill Revision","url":"https://stock-news.laohu8.com/highlight/detail?id=2520364386","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520364386?lang=en_us&edition=fundamental","pubTime":"2025-03-18 16:06","pubTimestamp":1742285180,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - The Indonesia Stock Exchange temporarily halted stock trading in the first session on Tuesday, March 18, 2025, at 11:19:31 Jakarta Automated Trading System  time. The trading halt came as the IHSG plummeted 5.02 percent to 5,146. The transaction value in the first session reached Rp3.39 trillion, involving 13.12 billion in 748 thousand transactions. All sectors were in the red zone.The Corporate Secretary of the Indonesia Stock Exchange , Kautsar Primadi Nurahmad, conveyed the reasons for implementing the trading halt through a written statement. \"With this, we inform that today, Tuesday, March 18, 2025, a temporary trading halt  has occurred in the trading system at the Indonesia Stock Exchange  at 11:19:31 Jakarta Automated Trading System  time, triggered by a 5 percent decrease in the Composite Stock Price Index .\"","market":"other","thumbnail":"https://statik.tempo.co/data/2024/04/16/id_1295098/1295098_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2024/04/16/id_1295098/1295098_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1987868/economist-links-ihsg-plummet-to-tni-bill-revision","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7124","IDX.AU","IDX"],"gpt_icon":0},{"id":"2518749702","title":"IDX Reports Rp246.1tn Securities Transactions, Launches Repo Trading on SPPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2518749702","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518749702?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:36","pubTimestamp":1741696573,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -The Indonesia Stock Exchange (IDX) reported that the Alternative Market Organizer System (SPPA) recorded strong performance in bond transactions throughout 2024. The total value of ","market":"sh","thumbnail":"https://statik.tempo.co/data/2021/07/13/id_1034700/1034700_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2021/07/13/id_1034700/1034700_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1985277/idx-reports-rp246-1tn-securities-transactions-launches-repo-trading-on-sppa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7124","BK7021","BK7049","STP.AU","IDX.AU","IDX"],"gpt_icon":0},{"id":"2517101967","title":"Insider Actions Highlight 3 Undervalued Small Caps In Global Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517101967","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517101967?lang=en_us&edition=fundamental","pubTime":"2025-03-07 17:09","pubTimestamp":1741338589,"startTime":"0","endTime":"0","summary":"In the current global market landscape, small-cap stocks are navigating a challenging environment characterized by declining consumer confidence and persistent inflation concerns, as seen in recent economic indicators. While major indices like the S&P 600 have faced pressure, this environment can often highlight opportunities for discerning investors who focus on companies with strong fundamentals and strategic insider actions.Top 10 Undervalued Small Caps With Insider Buying Globally. Click here to see the full list of 116 stocks from our Undervalued Global Small Caps With Insider Buying screener.Integral Diagnostics, a smaller company in the healthcare sector, recently reported half-year sales of A$252.87 million, up from A$231.25 million the previous year. Despite this growth, they faced a net loss of A$0.396 million compared to a larger loss previously. Insider confidence is evident with recent insider purchases over the last few months. However, financial challenges remain as inte","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-actions-highlight-3-undervalued-090949895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MNW.NZ","BK7104","BK8003","INTEU","PNR.AU","IDX.AU","BK7124"],"gpt_icon":1},{"id":"2517504903","title":"BUZZ-Australia's Integral Diagnostics rises on Citi's upgrade to 'Buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517504903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517504903?lang=en_us&edition=fundamental","pubTime":"2025-03-06 10:41","pubTimestamp":1741228870,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Integral Diagnostics rises on Citi's upgrade to 'Buy' rating** Shares of Integral Diagnostics IDX.AX rise 4.7% to A$2.25** Citi upgrades healthcare facilities provider to 'Buy' from 'Neutral,' keeps PT unchanged at A$2.70** Brokerage forecasts higher revenue and margins for IDX in FY26, buoyed by partial MRI de-regulation, potential lung cancer screening contract, and benefits from Capitol Health merger** Stock rose 5.1% earlier in the session** 13 analysts rate the stock \"buy\" or higher and 1 \"hold\"; their mean PT is A$3.13 – LSEG** Including session's gains, stock trims YTD decline to 22.3%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP06F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAJ.AU","IDX.AU"],"gpt_icon":0},{"id":"2517970664","title":"Integral Diagnostics Ltd  : Citi Upgrades Rating to Buy From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2517970664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517970664?lang=en_us&edition=fundamental","pubTime":"2025-03-06 10:01","pubTimestamp":1741226467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PO18Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","IDX.AU"],"gpt_icon":0},{"id":"2517986712","title":"Investors Shouldn't Be Too Comfortable With Integral Diagnostics' (ASX:IDX) Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2517986712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517986712?lang=en_us&edition=fundamental","pubTime":"2025-03-05 04:47","pubTimestamp":1741121224,"startTime":"0","endTime":"0","summary":"Last week's profit announcement from Integral Diagnostics Limited  was underwhelming for investors, despite headline numbers being robust. We think that the market might be paying attention to some underlying factors that they find to be concerning.To understand the value of a company's earnings growth, it is imperative to consider any dilution of shareholders' interests. Integral Diagnostics expanded the number of shares on issue by 59% over the last year. Therefore, each share now receives a smaller portion of profit. Per share metrics like EPS help us understand how much actual shareholders are benefitting from the company's profits, while the net income level gives us a better view of the company's absolute size. Check out Integral Diagnostics' historical EPS growth by clicking on this link.A Look At The Impact Of Integral Diagnostics' Dilution On Its Earnings Per Share . To sum it all up, Integral Diagnostics took a hit from unusual items which pushed its profit down; without that","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-shouldnt-too-comfortable-integral-204704945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IDX.AU","ISBC","INTEU","IDX"],"gpt_icon":0},{"id":"2516574896","title":"ASX Value Stocks: Uncovering 3 Companies Possibly Trading Below Fair Value Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2516574896","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516574896?lang=en_us&edition=fundamental","pubTime":"2025-03-04 03:04","pubTimestamp":1741028674,"startTime":"0","endTime":"0","summary":"As the ASX 200 rebounds with a 0.9% gain to 8,245 points, Australian investors are cautiously optimistic despite looming uncertainties such as upcoming U.S. tariffs. With all sectors in the green and Energy leading the charge, this environment presents an opportunity to explore stocks that may be trading below their fair value estimates; these stocks often offer potential for growth when market conditions stabilize or improve.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Overview: Cettire Limited operates as an online luxury goods retailer in Australia, the United States, and internationally, with a market cap of A$411.74 million.Overview: Integral Diagnostics Limited is a healthcare services company that provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals in Australia and New Zealand, with a market cap of A$798.95 million.Integral Diagnostics is trading at A$2.15, well below its estimated fair value of A$3.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-value-stocks-uncovering-3-190434091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7104","BK7017","BK7505","PNR.AU","XKO.AU","BK7117","IDX.AU","EOS.AU","BK7016","DMP.AU","BK7120","SDV.AU","BK7115","BK7095","BK7031","BK7503","ADT.AU","ACF.AU","RDY.AU","BK7049","CTT.AU","SHV.AU","XJO.AU","BK7021","BK7078","BK7124","INTEU","PBH.AU","BK7073","AD8.AU","NDO.AU","XAO.AU","BK7137"],"gpt_icon":0},{"id":"2516104540","title":"Don't Buy Integral Diagnostics Limited (ASX:IDX) For Its Next Dividend Without Doing These Checks","url":"https://stock-news.laohu8.com/highlight/detail?id=2516104540","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516104540?lang=en_us&edition=fundamental","pubTime":"2025-03-03 06:10","pubTimestamp":1740953459,"startTime":"0","endTime":"0","summary":"Integral Diagnostics Limited  is about to trade ex-dividend in the next 3 days. The ex-dividend date is two business days before a company's record date in most cases, which is the date on which the company determines which shareholders are entitled to receive a dividend. The ex-dividend date is of consequence because whenever a stock is bought or sold, the trade can take two business days or more to settle. This means that investors who purchase Integral Diagnostics' shares on or after the 6th of March will not receive the dividend, which will be paid on the 7th of April.The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. Integral Diagnostics has delivered 4.2% dividend","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dont-buy-integral-diagnostics-limited-221059094.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IDX.AU","INTEU","BK7124","IDX"],"gpt_icon":0},{"id":"2516539957","title":"Slammed 29% Integral Diagnostics Limited (ASX:IDX) Screens Well Here But There Might Be A Catch","url":"https://stock-news.laohu8.com/highlight/detail?id=2516539957","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516539957?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:14","pubTimestamp":1740777266,"startTime":"0","endTime":"0","summary":"Integral Diagnostics Limited ( ASX:IDX ) shareholders that were waiting for something to happen have been dealt a blow...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-idx/integral-diagnostics-shares/news/slammed-29-integral-diagnostics-limited-asxidx-screens-well","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7124","IDX.AU","IDX","INTEU"],"gpt_icon":0},{"id":"2514831397","title":"Small companies, big swings and four future leaders that stand out","url":"https://stock-news.laohu8.com/highlight/detail?id=2514831397","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514831397?lang=en_us&edition=fundamental","pubTime":"2025-02-28 13:12","pubTimestamp":1740719546,"startTime":"0","endTime":"0","summary":"In our reporting season update, I talk to Jason Guthrie about another volatile reporting season in the small to mid-cap end of the ASX. As always there have been many winners and losers and I discuss the trends we are seeing, including margin pressures and a reckoning for some of the best performing companies and sectors of recent months. I also outline the performance of a some of IML’s key holdings including Mayne Pharma , oOh!Media , Integral Diagnostics  and Light & Wonder .So, it’s been very volatile, but I think if we look at the reporting season in totality, the key messages we can take away are that consumers are still fairly price-conscious and value-conscious, but it’s not diabolical in terms of how the consumer is performing. If you look at the revenue lines that many of the companies have reported this reporting season, that’s actually held up OK. Companies are growing their top line o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/small-companies-big-swings-and-four-future-leaders-that-stand-out","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/small-companies-big-swings-and-four-future-leaders-that-stand-out","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7078","BK7045","OML.AU","LNW.AU","BK7052","BK7096","BK7508","MYX.AU","SWM.AU","BK7124","IDX.AU"],"gpt_icon":0},{"id":"2514359874","title":"Are Poor Financial Prospects Dragging Down Integral Diagnostics Limited (ASX:IDX Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514359874","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514359874?lang=en_us&edition=fundamental","pubTime":"2025-02-28 06:01","pubTimestamp":1740693707,"startTime":"0","endTime":"0","summary":"With its stock down 20% over the past week, it is easy to disregard Integral Diagnostics . We decided to study the company's financials to determine if the downtrend will continue as the long-term performance of a company usually dictates market outcomes. Particularly, we will be paying attention to Integral Diagnostics'  ROE today.ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.Check out our latest analysis for Integral Diagnostics. Earnings growth is an important metric to consider when valuing a stock. It’s important for an investor to know whether the market has priced in the company's expected earnings growth . Doing so will help them establish if the stock's future looks promising or ominous. What is IDX worth today?The  intrinsic value infographic ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/poor-financial-prospects-dragging-down-220147228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7124","IDX","IDX.AU","INTEU"],"gpt_icon":0},{"id":"2514635334","title":"Integral Diagnostics First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2514635334","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514635334?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:09","pubTimestamp":1740690551,"startTime":"0","endTime":"0","summary":"ASX:IDX Earnings and Revenue History February 27th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 1.4%. Earnings per share  missed analyst estimates.Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Healthcare industry in Australia.The company's shares are down 20% from a week ago.You should always think about risks. Case in point, we've spotted   3 warning signs for Integral Diagnostics  you should be aware of, and 2 of them are a bit concerning.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/integral-diagnostics-first-half-2025-210911625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IDX.AU","INTEU"],"gpt_icon":0},{"id":"2514873528","title":"Canaccord Genuity Upgrades Integral Diagnostics to Buy from Hold; Price Target is AU$2.90","url":"https://stock-news.laohu8.com/highlight/detail?id=2514873528","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514873528?lang=en_us&edition=fundamental","pubTime":"2025-02-27 17:23","pubTimestamp":1740648210,"startTime":"0","endTime":"0","summary":"Integral Diagnostics (ASX:IDX) has an average rating of outperform and price targets ranging from AU$2.50 to AU$3.87, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INTEU","IDX.AU"],"gpt_icon":0},{"id":"2514406842","title":"Integral Diagnostics Limited's (ASX:IDX) market cap dropped AU$178m last week; individual investors who hold 51% were hit as were institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2514406842","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514406842?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:53","pubTimestamp":1740606788,"startTime":"0","endTime":"0","summary":"Key Insights Integral Diagnostics' significant individual investors ownership suggests that the key decisions are...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-idx/integral-diagnostics-shares/news/integral-diagnostics-limiteds-asxidx-market-cap-dropped-au17","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IDX.AU","BK7124","INTEU","IDX"],"gpt_icon":0},{"id":"2514886770","title":"Integral Diagnostics Ltd (ASX:IDX) (H1 2025) Earnings Call Highlights: Strong Revenue Growth ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886770","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514886770?lang=en_us&edition=fundamental","pubTime":"2025-02-26 17:00","pubTimestamp":1740560456,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Integral Diagnostics Ltd  reported solid revenue growth of 7.8% and operating EBITDA growth of 8.2% for the first half of FY25.The company successfully completed its merger with Capital Health, which is expected to deliver at least $10 million in synergies, with most benefits realized in the first year.IDX has demonstrated strong patient satisfaction, with net promoter scores of 83 in Australia and 79 in New Zealand.The company is well-positioned to benefit from regulatory changes, including MRI deregulation and the national lung cancer screening program, which are expected to drive future growth.IDX has increased its free cash flow by 22.7% and improved its operating diluted earnings per share by 14.2%.IDX faced challenges with clinical staff shortages and labor cost inflation, particularly in regional areas, impacting margins.IDX's operating margin was constrained by higher clinical la","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/integral-diagnostics-ltd-asx-idx-090056598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["INTEU","IDX.AU","IDX"],"gpt_icon":0},{"id":"2514602187","title":"BUZZ-Australia's Integral Diagnostics slumps on HY results, estimate miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514602187","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514602187?lang=en_us&edition=fundamental","pubTime":"2025-02-26 08:44","pubTimestamp":1740530685,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Integral Diagnostics slumps on HY results, estimate miss** Shares of Integral Diagnostics IDX.AX fall 29% to A$2.030, their lowest levels since February 20, 2024** Stock is currently the top loser on ASX All Ordinaries Index .AORD** The medical imaging services provider reports HY loss attributable of A$396,000 , compared with a loss of A$66.8 million last year** Co also reports HY operating NPAT of A$9.8 million, missing consensus estimate of A$11.1 million ** Expects replacement and growth capex for FY25 to be between A$60 million and A$65 million** About 4.9 million shares change hands, 5.6 times the 30-day average of 870,753** Stock down 28.9% YTD, including current session's moves      ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nL3N3PH01R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDX.AU","BK7124"],"gpt_icon":0},{"id":"2514024151","title":"This ASX healthcare stock is crashing 30% on half year results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514024151","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514024151?lang=en_us&edition=fundamental","pubTime":"2025-02-26 08:06","pubTimestamp":1740528377,"startTime":"0","endTime":"0","summary":"The Integral Diagnostics Ltd  share price is having a day to forget on Wednesday. In morning trade, the ASX healthcare stock is down 30% to $2.00. This follows the release of the medical imaging services provider's half year results. ASX healthcare stock crashing 30% today  Revenue of $252.9 million Operating EBITDA of $46.2 million Operating net profit after tax of $8.8 million Statutory loss after tax of $0.4 million Interim dividend of 2.5 cents per share  What happened during the half?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/26/this-asx-healthcare-stock-is-crashing-30-on-half-year-results/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["INTEU","BK7124","IDX.AU"],"gpt_icon":0},{"id":"2514239540","title":"Integral Diagnostics Fiscal H1 Loss Narrows as Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2514239540","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514239540?lang=en_us&edition=fundamental","pubTime":"2025-02-26 07:22","pubTimestamp":1740525720,"startTime":"0","endTime":"0","summary":"Integral Diagnostics  reported Wednesday attributable loss per diluted share in the fiscal first half narrowed to AU$0.0016, from a loss of AU$0.2862 per diluted share a year earlier.Analysts polled by Visible Alpha were expecting earnings per share of AU$0.0006.Revenue from ordinary activities for the six months Dec. 31, 2024, was AU$252.9 million, up 9% from AU$231.3 million in the same period last year. Analysts surveyed by Visible Alpha expected AU$250.6 million.The radiologist and diagnostic imaging provider replacement and growth capital expenditure for the fiscal year to reach AU$60 million to AU$65 million.The board declared an interim dividend of AU$0.025 per share, unchanged from the previous reported period, payable on April 7 to shareholders on record as of March 7.Price : $2.86, Change: $-0.030, Percent Change: -1.04%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INTEU","IDX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":98,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDX.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-06","symbol":"IDX.AU","amount":0.025,"announcedDate":"2025-02-26","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-07","name":"INTEGRAL DIAGNOSTICS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-07","payableDate":"2025-03-07","currency":"AUD","dateTimestamp":1741179600000,"payDate":"2025-04-07"},{"date":"2025-02-25","symbol":"IDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740438000000,"name":null,"time":"","dateTimestamp":1740402000000,"actualEps":null},{"date":"2024-08-30","symbol":"IDX.AU","amount":0.033,"announcedDate":"2024-08-27","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-02","defaultRemindTime":1724976000000,"name":"INTEGRAL DIAGNOSTICS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-03","payableDate":"2024-09-02","currency":"AUD","dateTimestamp":1724940000000,"payDate":"2024-10-03"},{"date":"2024-08-27","symbol":"IDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724716800000,"name":null,"time":"","dateTimestamp":1724680800000,"actualEps":null},{"date":"2024-02-29","symbol":"IDX.AU","amount":0.025,"announcedDate":"2024-02-19","type":"dividend","market":"AU","newRecordDate":"2024-03-01","defaultRemindTime":1709161200000,"name":"Integral Diagnostics Ltd","recordDate":"2024-04-02","payableDate":"2024-03-01","currency":"AUD","dateTimestamp":1709125200000,"payDate":"2024-04-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-28","recordDate":"2020-08-31","paymentDate":"2020-10-01","value":0.04,"currency":"AUD"},{"executeDate":"2021-03-01","recordDate":"2021-03-02","paymentDate":"2021-04-06","value":0.055,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-10-06","value":0.07,"currency":"AUD"},{"executeDate":"2022-03-01","recordDate":"2022-03-02","paymentDate":"2022-04-04","value":0.04,"currency":"AUD"},{"executeDate":"2022-09-01","recordDate":"2022-09-02","paymentDate":"2022-10-05","value":0.03,"currency":"AUD"}]}}